Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;88(8):3813-3818.
doi: 10.1111/bcp.15330. Epub 2022 Apr 6.

Psoriasis risk after beta-blocker exposure: Description of a pharmacovigilance signal

Brahim Azzouz  1   2 , Apolline De Guizelin  1 , Aude Lambert  3 , Audrey Fresse  4 , Aurore Morel  1 , Thierry Trenque  1   2
Affiliations
Free article

Psoriasis risk after beta-blocker exposure: Description of a pharmacovigilance signal

Brahim Azzouz et al. Br J Clin Pharmacol. 2022 Aug.
Free article

Abstract

Aim: We aimed to investigate French pharmacovigilance data. The objective was to characterize psoriatic conditions that occurred after beta-blocker (BB) exposure and bring to light a possible pharmacovigilance signal.

Methods: Spontaneous reports of psoriatic conditions recorded in the French National Pharmacovigilance Database (FPVD) between 1985 and 2019 were extracted. We performed a retrospective, descriptive analysis of reports linked to BB exposure. Association between psoriasis risk and BB exposure was assessed using a case/noncase study.

Results: Two hundred and twenty-five reports of psoriatic conditions after BB exposure were recorded in the FPVD during the study period. Both cardioselective and noncardioselective, topical and systemic BBs are involved. Therapeutic indication of BB was mainly hypertension. Mean time to onset was 5 months and outcome was favourable in 68% after BB discontinuation. These features were concordant with those of literature reports. The reporting odds ratio (ROR) was 8.95 (95% confidence interval 7.75-10.33).

Conclusion: We highlighted a statistically significant disproportionality which constitutes a pharmacovigilance signal. Psoriasis risk with BBs is a class effect. Increasing surveillance during the first year of BB exposure is needed.

Keywords: beta-blocker; drug reaction; geriatrics; hypertension; pharmacoepidemiology; psoriasis; quality of life.

PubMed Disclaimer

References

REFERENCES

    1. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205-212. doi:10.1111/jdv.13854
    1. Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 2020;323(19):1945-1960. doi:10.1001/jama.2020.4006
    1. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol. 2000;1(3):159-165.
    1. Rongioletti F, Fiorucci C, Parodi A. Psoriasis induced or aggravated by drugs. J Rheumatol Suppl. 2009;83:59-61. doi:10.3899/jrheum.090227
    1. Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthetic Dermatol. 2010;3(1):32-38.

Publication types

MeSH terms

Substances

LinkOut - more resources